U.S. Stock Movement | Pfizer's stock price rises over 2% after reaching a drug pricing agreement with Trump
I'm PortAI, I can summarize articles.
Pfizer's stock price rose, and as of the time of writing, the stock is up over 2.3%, trading at $24.4. In terms of news, U.S. President Trump announced a drug pricing agreement with Pfizer, which will voluntarily sell its drugs at lower prices through the Medicaid program
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments